The Center for RNA Therapeutics
GPTKB entity
Statements (58)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Research_Institute
|
gptkbp:affiliatedWith |
gptkb:University_of_Massachusetts_Medical_School
|
gptkbp:aimsTo |
advance RNA technology
develop RNA-based treatments |
gptkbp:collaboratesWith |
academic institutions
biotechnology companies |
gptkbp:conducts |
clinical trials
preclinical studies |
gptkbp:develops |
therapeutic RNA molecules
|
gptkbp:engagesIn |
public outreach
|
gptkbp:establishedIn |
2015
|
gptkbp:focusesOn |
gptkb:RNA_therapeutics
disease treatment |
gptkbp:hasCollaborationsWith |
pharmaceutical companies
|
gptkbp:hasImpactOn |
healthcare advancements
|
gptkbp:hasPart |
research teams
laboratory facilities bioinformatics team clinical research unit regulatory compliance team clinical trial management team |
gptkbp:hasResearchFocus |
genetic disorders
infectious diseases cancer therapies |
gptkbp:hasResearchInterest |
mRNA therapeutics
gene editing gene silencing RNA delivery systems |
gptkbp:historicalResearch |
scientific journals
|
gptkbp:hosts |
workshops
|
https://www.w3.org/2000/01/rdf-schema#label |
The Center for RNA Therapeutics
|
gptkbp:isActiveIn |
community education
|
gptkbp:isDedicatedTo |
improving patient outcomes
|
gptkbp:isEngagedIn |
translational research
scientific collaborations |
gptkbp:isFocusedOn |
patient-centered research
therapeutic applications of RNA |
gptkbp:isInvolvedIn |
drug development
biomedical innovation regulatory affairs |
gptkbp:isKnownFor |
cutting-edge technology
innovative research |
gptkbp:isLedBy |
scientific director
|
gptkbp:isLocatedIn |
gptkb:Worcester,_Massachusetts
|
gptkbp:isPartOf |
biomedical research community
RNA research network |
gptkbp:isRecognizedBy |
scientific community
|
gptkbp:isSupportedBy |
federal funding
philanthropic donations |
gptkbp:offers |
internships
graduate programs |
gptkbp:participatesIn |
conferences
|
gptkbp:promotes |
collaborative research
|
gptkbp:provides |
research facilities
|
gptkbp:receivesFundingFrom |
government grants
private investors |
gptkbp:supports |
startups
|
gptkbp:utilizes |
nanotechnology
|